Content about Acura Pharmaceuticals

March 6, 2013
Nexafed gains distribution in Kerr Drug

Acura Pharmaceuticals announced that its next-generation pseudoephedrine with abuse-deterrent technology will now be stocked by North Carolina's Kerr Drug.

December 27, 2012
Acura Pharmaceuticals supports launch of Nexafed PSE with pharmacist education website

In support of its December launch of the pseudoehedrine product Nexafed, Acura Pharmaceuticals recently kicked off a national e-mail campaign to help drive pharmacists to the Nexafed website with content specifically designed for the pharmacist audience, including infographics, graphic representations of study data and a behind-the-scenes look at Nexafed's abuse-deterrent technology.

November 15, 2012
ReportersNotebook — Over the Counter, 11/19/12

Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine.

November 8, 2012
Acura Pharmaceuticals moves forward with plans to launch diversion-hindering PSE product

Acura Pharmaceuticals on Wednesday shared with analysts details on its launch strategy of Nexafed, a pseudoephedrine formulated such that in inhibits the diversion to methamphetamnine.

October 29, 2012
Acura Pharmaceuticals introduces PSE product that will be less attractive to 'meth cooks'

Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine.

January 24, 2012
Oxecta now commercially available

A pain medication that utilizes Acura Pharmaceuticals' Aversion technology now is commercially available.

June 22, 2011
Pfizer, Acura get FDA OK for Oxecta

The Food and Drug Administration has approved a medication designed to treat acute and chronic moderate to severe pain, where the use of an opioid analgesic is suitable.

February 14, 2011
FDA grants Acurox priority review

The Food and Drug Administration has accepted for review an application for a pain medication designed to thwart drug abusers.

December 20, 2010
King, Acura seek regulatory approval for Acurox

Drug makers King Pharmaceuticals and Acura Pharmaceuticals have submitted a regulatory approval application to the Food and Drug Administration for an opioid pain reliever.

© 2013 Drug Store News. All Rights Reserved.